Patent details

Basic Information

Publication number:

EP2101821

PCT Application Number:

PCT/US/2007/087553

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP078656790

PCT Publication Number:

WO/2008/074032

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

FACTOR VIIA- (POLY) SIALIC ACID CONJUGATE HAVING PROLONGED IN VIVO HALF-LIFE

French Title of Invention:

CONJUGUÉ DU FACTEUR VIIA ET DE L'ACIDE (POLY)SIALIQUE PRÉSENTANT UNE DEMI-VIE IN VIVO PROLONGÉE

German Title of Invention:

FAKTOR-VIIA-(POLY)SIALSÄUREKONJUGAT MIT VERLÄNGERTER IN-VIVO-HALBWERTSZEIT

SPC Number:

Dates

Filing date:

14/12/2007

Grant date:

13/08/2014

EP Publication Date:

13/08/2014

PCT Publication Date:

19/06/2008

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

23/09/2009

EP B1 Publication Date:

13/08/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/12/2014

Expiration date:

14/12/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

14/12/2007

 

 

Name:

Baxter Healthcare SA

Address:

Thurgauerstrasse 130, 8152 Glattpark (Opfikon), Switzerland (CH)

Name:

Baxter International Inc.

Address:

One Baxter Parkway, Deerfield, IL 60015, United States (US)

Inventor

1

Name:

TURECEK Peter

Address:

Austria (AT)

2

Name:

CANAVAGGIO Michel

Address:

Austria (AT)

3

Name:

SCHEIFLINGER Friedrich

Address:

Austria (AT)

4

Name:

SIEKMANN Juergen

Address:

Austria (AT)

Priority

Priority Number:

875217 P

Priority Date:

15/12/2006

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 47/48;

Filing date	Document type	Number of pages